Antiphospholipid Syndrome

Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events
Dionysis Nikolopoulos, Catherine Loukogiannaki, George Sentis, Panagiotis Garantziotis, Theodora Manolakou, Noemin Kapsala, Myrto Nikoloudaki, Antigone Pieta, Sofia Flouda, Ioannis Parodis, George Bertsias, Antonis Fanouriakis, Anastasia Filia, Dimitrios T Boumpas

Annals of the Rheumatic Diseases Apr 2024, ard-2024-225664; DOI: 10.1136/ard-2024-225664
Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome
Chenyang Lu, Rui Gao, Pingying Qing, Xun Zeng, Xin Liao, Meng Cheng, Lang Qin, Yi Liu

Annals of the Rheumatic Diseases May 2024, 83 (5) 624-637; DOI: 10.1136/ard-2023-224930
Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’
Francesc A Miro-Mur, Jaume Alijotas-Reig, Ariadna Anunciacion-Llunell, Joana Marques-Soares, Enrique Esteve-Valverde, Jose Pardos-Gea

Annals of the Rheumatic Diseases Mar 2024, 83 (3) e2; DOI: 10.1136/ard-2023-225042
Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Miro-Mur et al
Doruk Erkan, Medha Barbhaiya, Stephane Zuily, Maria Laura Bertolaccini, Rohan Willis, Katrien Devreese

Annals of the Rheumatic Diseases Mar 2024, 83 (3) e3; DOI: 10.1136/ard-2023-225054
Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Tang et al
Medha Barbhaiya, Stephane Zuily, Alison M Hendry, Florian Manneville, Francis Guillemin, Karen H Costenbader, Doruk Erkan

Annals of the Rheumatic Diseases Mar 2024, 83 (3) e5; DOI: 10.1136/ard-2023-225026
Correspondence on “ACR/EULAR antiphospholipid syndrome classification criteria”
Jan Damoiseaux, Joyce van Beers

Annals of the Rheumatic Diseases Mar 2024, 83 (3) e6; DOI: 10.1136/ard-2023-225067
Response to: Correspondence on ‘ACR/EULAR antiphospholipid syndrome classification criteria’ by Damoiseaux and van Beers
Medha Barbhaiya, Stephane Zuily, Maria Laura Bertolaccini, Rohan Willis, Katrien Devreese, Doruk Erkan

Annals of the Rheumatic Diseases Mar 2024, 83 (3) e7; DOI: 10.1136/ard-2023-225074
Correspondence on ‘Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis’
Chuanhui Xu

Annals of the Rheumatic Diseases Dec 2022, 81 (12) e246; DOI: 10.1136/annrheumdis-2020-219056
Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’
Zhuochao Zhou, Fan Wang, Yue Sun, Jialin Teng, Honglei Liu, Xiaobing Cheng, Yutong Su, Hui Shi, Yijun You, Chengde Yang, Junna Ye

Annals of the Rheumatic Diseases Dec 2022, 81 (12) e248; DOI: 10.1136/annrheumdis-2020-218950
Response to: ‘Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’ by Zhou et al
Maria G Tektonidou, Angela Tincani, Michael M Ward

Annals of the Rheumatic Diseases Dec 2022, 81 (12) e249; DOI: 10.1136/annrheumdis-2020-219048

Main menu

Antiphospholipid Syndrome

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Antiphospholipid Syndrome

Pages